{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent investigations into prostate cancer metastasis have identified MIR5001 as a critical miRNA that functions in tandem with androgen receptor (AR) signaling. Elevated AR levels, as observed in metastatic prostate tumors, are associated with increased activation of AR target genes and enhanced cell migration. MIR5001 appears to be part of this regulatory network, potentially mediating pro-metastatic signals in response to androgen stimulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMechanistic studies suggest that upon androgen treatment or AR augmentation, MIR5001 expression is modulated to promote cellular mobility and invasiveness. Under conditions of androgen abundance, this miRNA may facilitate the activation of downstream pathways that drive metastasis, whereas in androgen-depleted environments, AR-dependent suppression of cell invasiveness indicates a nuanced, dual role for MIR5001 in prostate cancer progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn summary, MIR5001 emerges as a key regulatory factor that interfaces with AR signaling to influence the metastatic behavior of prostate cancer cells. Its context-dependent modulation—supporting migration and invasion under androgen stimulation while contributing to suppressed motility when androgens are low—underscores its potential as both a prognostic marker and a therapeutic target in managing metastatic prostate cancer."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Chieh Huo, Ying-Yu Kuo, Ching-Yu Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The miRNAs 203a/210-3p/5001-5p regulate the androgen/androgen receptor/YAP-induced migration in prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.70106"}], "href": "https://doi.org/10.1002/cam4.70106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39149855"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39149855"}]}]}]}